Blood Res.  2023 Dec;58(4):231-234. 10.5045/br.2023.2023141.

T-cell large granular lymphocytic leukemia with low-grade bone marrow involvement complicated by acquired pure red cell aplasia

• Strasser B
• Heibl S
• Thaler J
• Haushofer A

• KMID: 2550203
• DOI: http://doi.org/10.5045/br.2023.2023141

Figure

• 

  Fig. 1 T-LGL cells in the peripheral blood smear.

• 

  Fig. 2 Absence of erythropoietic precursor in bone marrow.

• 

  Fig. 3 (A) T-prolymphocytic leukemia. (B) Natural killer cell-large granular lymphocytic leukemia. (C) Adult T-cell lymphoma. (D) Sezary syndrome.

Reference

1. Park SH, Lee YJ, Kim Y, Kim HK, Lim JH, Jo JC. 2023; T-large granular lymphocytic leukemia. Blood Res. 58(S1):S52–7. DOI: 10.5045/br.2023.2023037. PMID: 37026382. PMCID: PMC10133854.

2. Nakazawa H, Sakai K, Ohta A, et al. 2022; Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan. Blood Adv. 6:6282–90. DOI: 10.1182/bloodadvances.2021006486. PMID: 35522950. PMCID: PMC9806328.

3. Alaggio R, Amador C, Anagnostopoulos I, et al. 2022; The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 36:1720–48. DOI: 10.1038/s41375-022-01620-2. PMID: 35732829. PMCID: PMC9214472.

4. Bareau B, Rey J, Hamidou M, et al. 2010; Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica. 95:1534–41. DOI: 10.3324/haematol.2009.018481. PMID: 20378561. PMCID: PMC2930955.

5. Foucar K. 2007; Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome. Am J Clin Pathol. 127:496–510. DOI: 10.1309/KWJYBCCGTB90B6AE. PMID: 17369126.

6. Goyal T, Thakral B, Wang SA, et al. 2018; T-cell large granular lymphocytic leukemia and coexisting B-cell lymphomas: a study from the bone marrow pathology group. Am J Clin Pathol. 149:164–71. DOI: 10.1093/ajcp/aqx146. PMID: 29365010.

7. Nicolae A, Ganapathi KA, Pham TH, et al. 2017; EBV-negative aggressive NK-cell leukemia/lymphoma: clinical, pathologic, and genetic features. Am J Surg Pathol. 41:67–74. DOI: 10.1097/PAS.0000000000000735. PMID: 27631517. PMCID: PMC5159195.

8. Vlachaki E, Diamantidis MD, Klonizakis P, Haralambidou-Vranitsa S, Ioannidou-Papagiannaki E, Klonizakis I. 2012; Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. ScientificWorldJournal. 2012:475313. DOI: 10.1100/2012/475313. PMID: 22593689. PMCID: PMC3349208. PMID: 97e026bf3ede419e94d242b7e6b3a426.

9. Fujishima N, Kohmaru J, Koyota S, et al. 2021; Clonal hematopoiesis in adult pure red cell aplasia. Sci Rep. 11:2253. DOI: 10.1038/s41598-021-81890-5. PMID: 33500526. PMCID: PMC7838416. PMID: 5b01912c18ce4399a6aa2f25513dfa7f.

10. Kawakami T, Sekiguchi N, Kobayashi J, et al. 2018; Frequent STAT3 mutations in CD8(+) T cells from patients with pure red cell aplasia. Blood Adv. 2:2704–12. DOI: 10.1182/bloodadvances.2018022723. PMID: 30337298. PMCID: PMC6199660.

11. Wang H, Niu H, Zhang T, Xing L, Shao Z, Fu R. 2021; Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia. Hematology. 26:444–6. DOI: 10.1080/16078454.2021.1929694. PMID: 34153199.

12. Korde N, Zhang Y, Loeliger K, et al. 2016; Monoclonal gammopathy-associated pure red cell aplasia. Br J Haematol. 173:876–83. DOI: 10.1111/bjh.14012. PMID: 26999424. PMCID: PMC5549779.